受强制性开放获取政策约束的文章 - Valentín Ortiz-Maldonado了解详情
无法在其他位置公开访问的文章：1 篇
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era
A Mussetti, L Bento, M Bastos-Oreiro, B Rius-Sansalvador, C Albo, ...
Bone Marrow Transplantation 58 (6), 673-679, 2023
强制性开放获取政策： Government of Spain
可在其他位置公开访问的文章：25 篇
CART19-BE-01: a multicenter trial of ARI-0001 cell therapy in patients with CD19+ relapsed/refractory malignancies
V Ortíz-Maldonado, S Rives, M Castellà, A Alonso-Saladrigues, ...
Molecular Therapy 29 (2), 636-644, 2021
强制性开放获取政策： Government of Spain
Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: experience from an academic phase I clinical trial
M Castella, M Caballero-Baños, V Ortiz-Maldonado, ...
Frontiers in immunology 11, 482, 2020
强制性开放获取政策： Government of Spain
Development of a novel anti-CD19 chimeric antigen receptor: a paradigm for an affordable CAR T cell production at academic institutions
M Castella, A Boronat, R Martín-Ibáñez, V Rodríguez, G Suñé, ...
Molecular Therapy-Methods & Clinical Development 12, 134-144, 2019
强制性开放获取政策： Banking Foundation "la Caixa", European Commission, Government of Spain
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
M Kwon, G Iacoboni, JL Reguera, LL Corral, RH Morales, ...
Haematologica 108 (1), 110, 2022
强制性开放获取政策： Government of Spain
Anakinra for refractory cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy
N Gazeau, EC Liang, JM Voutsinas, P Barba, G Iacoboni, M Kwon, ...
Transplantation and cellular therapy 29 (7), 430-437, 2023
强制性开放获取政策： US National Institutes of Health
Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies
CA Garcia-Prieto, L Villanueva, A Bueno-Costa, V Davalos, ...
JNCI: Journal of the National Cancer Institute 114 (3), 436-445, 2022
强制性开放获取政策： Banking Foundation "la Caixa", Cancer Research UK, Government of Spain …
Lymphodepletion–an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
B Lickefett, L Chu, V Ortiz-Maldonado, L Warmuth, P Barba, M Doglio, ...
Frontiers in Immunology 14, 1303935, 2023
强制性开放获取政策： European Commission
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
A Oliver-Caldes, R Jiménez, M Español-Rego, MT Cibeira, ...
Journal for Immunotherapy of Cancer 9 (12), 2021
强制性开放获取政策： Banking Foundation "la Caixa", European Commission, Government of Spain
Results of ARI-0001 CART19 cells in patients with chronic lymphocytic leukemia and Richter’s transformation
V Ortiz-Maldonado, G Frigola, M Español-Rego, O Balagué, ...
Frontiers in Oncology 12, 828471, 2022
强制性开放获取政策： Banking Foundation "la Caixa", Government of Spain
CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
C Bueno, S Barrera, A Bataller, V Ortiz-Maldonado, N Elliot, S O’Byrne, ...
Blood, The Journal of the American Society of Hematology 140 (1), 38-44, 2022
强制性开放获取政策： Banking Foundation "la Caixa", Cancer Research UK, UK Medical Research …
Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
V Ortiz-Maldonado, S Rives, M Español-Rego, A Alonso-Saladrigues, ...
Journal for immunotherapy of cancer 9 (12), 2021
强制性开放获取政策： Government of Spain
The biology behind PI3K inhibition in chronic lymphocytic leukaemia
V Ortiz-Maldonado, M García-Morillo, J Delgado
Therapeutic advances in hematology 6 (1), 25-36, 2015
强制性开放获取政策： Government of Spain
Manufacturing and management of CAR T-cell therapy in “COVID-19’s time”: central versus point of care proposals
I Ortiz de Landazuri, N Egri, G Muñoz-Sánchez, V Ortiz-Maldonado, ...
Frontiers in Immunology 11, 573179, 2020
强制性开放获取政策： Banking Foundation "la Caixa", Government of Spain
CAR-T after stem cell transplantation in B-cell lymphoproliferative disorders: are they really autologous or allogenic cell therapies?
A Bartoló-Ibars, M Uribe-Herranz, G Muñoz-Sánchez, C Arnaldos-Pérez, ...
Cancers 13 (18), 4664, 2021
强制性开放获取政策： Banking Foundation "la Caixa", European Commission, Government of Spain
Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease
V Ortiz‐Maldonado, A Alonso‐Saladrigues, M Español‐Rego, ...
American Journal of Hematology 97 (6), 731-739, 2022
强制性开放获取政策： Banking Foundation "la Caixa", Government of Spain
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals
TF Aiello, P Puerta-Alcalde, M Chumbita, C Lopera, P Monzó, A Cortes, ...
Journal of Antimicrobial Chemotherapy 78 (6), 1454-1459, 2023
强制性开放获取政策： Government of Spain
Biomarkers of efficacy and safety of the academic BCMA-CART ARI0002h for the treatment of refractory multiple myeloma
A Oliver-Caldes, M Español-Rego, A Zabaleta, V González-Calle, ...
Clinical Cancer Research 30 (10), 2085-2096, 2024
强制性开放获取政策： Banking Foundation "la Caixa"
The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed …
N Martínez‐Cibrián, V Ortiz‐Maldonado, M Español‐Rego, A Blázquez, ...
British Journal of Haematology 204 (2), 525-533, 2024
强制性开放获取政策： Banking Foundation "la Caixa", Government of Spain
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential …
AB Moreno-Castaño, S Fernández, H Ventosa, M Palomo, ...
Journal for Immunotherapy of Cancer 11 (4), 2023
强制性开放获取政策： Government of Spain
出版信息和资助信息由计算机程序自动确定